PubVisualPubVisual Book a Demo
Resources Blog About Contact Book a 30-Minute Demo →
About us

The publication was never the finish line.

PubVisual exists for the moment after the paper goes out, when years of work either reaches the physicians it was written for, or quietly doesn’t. This page is the story of why we care about that moment so much.

Why we exist

Somebody spends years getting a study right. And then it becomes a PDF.

Every publication we’ve ever been handed had the same story behind it. A team that sweated the endpoints, survived the reviews, and got the science right. Then the paper went out into a world where most physicians never make it past the abstract.

That gap bothered us enough to build a company around it. Not because the science is broken. Not because the teams behind it aren’t trying, they absolutely are. The format is what gives out: a linear paper, identical for every reader, finished before it’s opened.

So we rebuild the story. Same science, same claims, nothing added and nothing bent. Just shaped so a physician can actually explore it, in the time they have, in the order they care about, with a trusted voice nearby when it helps.

The part we love most is quiet: a cardiologist, somewhere, on a Tuesday evening, actually finishing the story a research team spent years telling. That’s the whole company. Everything else is craft in service of that moment.

How we help

One paper. Many ways in.

This is what happens to a publication in our hands. It stays exactly what it was, and it becomes something each physician can enter their own way.

Your approved publication The study your team already fought for

Every claim keeps its reference. Nothing new is created.

Some want to watch itThe story told visually, start to finish, in minutes
Dr. David Okonkwo presses play between two clinic patients
Some want to explore itTheir own route through the data, as deep as they like
Dr. Daniel Okafor goes straight for the subgroup analysis
Some want to hear a peerA respected expert speaking on the science, inside the story
Dr. Anne Lindqvist listens to a colleague she’s cited for years

You bring the publication and the therapeutic-area context. We do the heavy lifting, the mapping, the design, and the build.

How we work

Four things we believe.

One
You did the hard part.

The science is yours and so is the credit. Our name goes on the craft of delivering it, never on the discovery. When it works, your team is the hero of the story.

Two
We do the heavy lifting.

You bring the paper and the context. The mapping, the design, the build, and the versions are on us. Your team’s calendar should barely notice we’re there.

Three
Compliance is part of the craft.

Zero new claims, ever. Every frame maps back to the approved source, so your review process meets work that was built for it from the first frame.

Four
Physicians set the pace.

Nothing we build is pushed at anyone. Physicians explore in their own time, at their own depth, and ask for more only when they want it. Respect reads better than reach.

PubVisual by RedNovius

PubVisual is the product. RedNovius is the company behind it. One team, one door, and the same people on the other side of every email. If you’ve seen our work at a congress booth or on an MSL’s iPad, that was us too.

Say hello

We’d love to meet the team behind your science.

Thirty minutes and one real example is the fastest way to see if we fit. Or just write to us. That works too.

Questions

Frequently asked questions

PubVisual is our product family: Core, Engage, Smart Pathways, and KOL. RedNovius is the company that builds and runs it. You’ll see both names, but it’s one team and one door.

Very likely. Oncology, cardiology, rare disease, immunology, neurology, respiratory, hematology, endocrinology, the list keeps growing. And if yours isn’t on it yet, bring it anyway. The pattern travels; the therapeutic area is just where we start.

The publication, and whoever knows the therapeutic area best. That’s genuinely it. The mapping, the design, and the build are our job, not yours.

No. The science, the strategy, and the review process stay exactly where they are, with you. We take the finished, approved story and give it more ways to be understood. Think of us as the last mile, not a new department.